What is future of Marksans Pharma share?
Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 86 in its research report dated February 16, 2022.
Should I buy Marksans Pharma share?
Avoid buying this junk, this has no future growth, may go up to certain level to trap retail investors but will again come back to 40-50 level.
Is Marksans Pharma Debt Free?
What Is Marksans Pharma’s Net Debt? The image below, which you can click on for greater detail, shows that at March 2019 Marksans Pharma had debt of ₹1.31b, up from ₹1.17b in one year. However, because it has a cash reserve of ₹335.4m, its net debt is less, at about ₹972.8m.
Why is Marksans Pharma share falling?
Drug maker Marksans Pharma’s shares fell on Monday after its board of directors approved a proposed equity buyback.
What is the target of Marksan Pharma?
MARKSANS Weekly Target
| 4th UP Target | 54.19 |
|---|---|
| 2nd UP Target | 51.99 |
| 1st UP Target | 51.15 |
| 1st DOWN Target | 48.75 |
| 2nd DOWN Target | 47.91 |
Will marksans increase share price?
quote is equal to 51.200 INR at 2022-09-17. Based on our forecasts, a long-term increase is expected, the “Marksans Pharma Ltd” stock price prognosis for 2027-09-10 is 120.785 INR. With a 5-year investment, the revenue is expected to be around +135.91%. Your current $100 investment may be up to $235.91 in 2027.
What is the target of Marksans Pharma?
What is the buyback price of Marksans Pharma?
Rs ₹60 per share
The Marksans Pharma Buyback is being offered at Rs ₹60 per share per equity share.
Is marksans Pharma a good company?
Marksans Pharma is rated 3.5 out of 5, based on 140 reviews by employees on AmbitionBox. Marksans Pharma is known for Skill development which is rated at the top and given a rating of 3.5. However, Salary & Benefits is rated the lowest at 3.0 and can be improved.
What is news about marksans Pharma?
Marksans Pharma stock up by 14% as board considers share buyback. The stock reached its 52-week high on July 6, 2021, at Rs93. 50, and its 52-week low on June 20, 2022, at Rs38.
Is marksans Pharma a good stock for long term?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Marksans Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.